Steve will also be an integral member of UCB’s European leadership team and will report to Khoso Baluch, senior VP, European biopharma brands and solutions.
Steve joins UCB from Gilead Sciences where he was general manager of their Canadian operations and responsible for all aspects of running the Canadian office.
Commenting on his appointment Steve said, “I am excited to be joining such a dynamic organisation and I relish the opportunity to further UCB’s focus of putting patients at the core of our operations.
Steve replaces Matthew Speers who left UCB in April of this year.
